Financial Advisors Network’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.87M | Sell |
31,690
-4,104
| -11% | -$344K | 0.35% | 52 |
|
|
2026
Q1 | $2.87M | Buy |
35,794
+3,227
| +10% | +$266K | 0.4% | 41 |
|
|
2025
Q4 | $2.78M | Buy |
32,567
+8,707
| +36% | +$715K | 0.38% | 49 |
|
|
2025
Q3 | $1.86M | Buy |
23,860
+3,071
| +15% | +$240K | 0.26% | 62 |
|
|
2025
Q2 | $1.63M | Buy |
20,789
+845
| +4% | +$63K | 0.25% | 62 |
|
|
2025
Q1 | $1.45M | Buy |
19,944
+355
| +2% | +$25.4K | 0.24% | 63 |
|
|
2024
Q4 | $1.45M | Buy |
+19,589
| New | +$1.37M | 0.24% | 61 |
|
|
2023
Q4 | $1.23M | Hold |
16,148
| – | – | 0.25% | 54 |
|
|
2023
Q3 | $1.12M | Buy |
+16,148
| New | +$1.3M | 0.25% | 52 |
|
|
2022
Q4 | $1.17M | Buy |
15,721
+2,847
| +22% | +$219K | 0.31% | 49 |
|
|
2022
Q3 | $1.06M | Buy |
12,874
+157
| +1% | +$15.1K | 0.31% | 48 |
|
|
2022
Q2 | $1.21M | Sell |
12,717
-84
| -0.7% | -$8.7K | 0.34% | 47 |
|
|
2022
Q1 | $1.51M | Sell |
12,801
-426
| -3% | -$47.8K | 0.37% | 45 |
|
|
2021
Q4 | $1.71M | Buy |
13,227
+1,133
| +9% | +$132K | 0.39% | 46 |
|
|
2021
Q3 | $1.4M | Sell |
12,094
-35
| -0.3% | -$4K | 0.32% | 48 |
|
|
2021
Q2 | $1.26M | Sell |
12,129
-302
| -2% | -$28.5K | 0.37% | 48 |
|
|
2021
Q1 | $1.04M | Hold |
12,431
| – | – | 0.34% | 51 |
|
|
2020
Q4 | $1.13M | Hold |
12,431
| – | – | 0.39% | 45 |
|
|
2020
Q3 | $992K | Hold |
12,431
| – | – | 0.39% | 45 |
|
|
2020
Q2 | $859K | Buy |
12,431
+1,196
| +11% | +$85K | 0.35% | 47 |
|
|
2020
Q1 | $706K | Hold |
11,235
| – | – | 0.34% | 47 |
|
|
2019
Q4 | $874K | Hold |
11,235
| – | – | 0.4% | 48 |
|
|
2019
Q3 | $824K | Hold |
11,235
| – | – | 0.42% | 46 |
|
|
2019
Q2 | $798K | Hold |
11,235
| – | – | 0.43% | 45 |
|
|
2019
Q1 | $639K | Sell |
11,235
-270
| -2% | -$15.4K | 0.37% | 52 |
|
|
2018
Q4 | $587K | Buy |
+11,505
| New | +$582K | 0.37% | 57 |
|
|
2018
Q2 | $551K | Buy |
+11,355
| New | +$530K | 0.33% | 57 |
|
|
2017
Q4 | $448K | Buy |
11,934
+24
| +0.2% | +$881 | 0.3% | 68 |
|
|
2017
Q3 | $434K | Hold |
11,910
| – | – | 0.34% | 57 |
|
|
2017
Q2 | $469K | Buy |
+11,910
| New | +$435K | 0.39% | 49 |
|
|
2017
Q1 | – | Sell |
-78
| Closed | -$2.51K | – | 207 |
|
|
2016
Q4 | $2.51K | Buy |
+78
| New | +$2.53K | ﹤0.01% | 412 |
|
Other funds holding EW
Financial Advisors Network's EW Position: Q2 2026 in Review
Financial Advisors Network reduced its Edwards Lifesciences (EW) stake by 11% in Q2 2026, selling an estimated $344K and leaving 31,690 shares worth $2.87M. The position accounts for 0.35% of the portfolio, ranked #52.
Financial Advisors Network first reported a position in EW in Q4 2016 and has held it in 31 quarters since. 1,333 funds tracked by Wall St. Rank hold EW as of Q2 2026.
- Financial Advisors Network held 31,690 shares of Edwards Lifesciences worth $2.87M as of Q2 2026.
- Financial Advisors Network sold 4,104 Edwards Lifesciences shares in Q2 2026, an estimated $344K.
- Edwards Lifesciences made up 0.35% of Financial Advisors Network's portfolio in Q2 2026, its #52 holding.
- Financial Advisors Network first reported a position in Edwards Lifesciences in Q4 2016 and has held it in 31 quarters since.
- 1,333 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.
Based on Financial Advisors Network's 13F filing for Q2 2026, filed 14 Aug 2026.